Cancer
Breast Lobular Neoplasia
CI-CAN-00000109LIN · LNExplore in graph →
Non-malignant12 active trials
- NCIt
- C27939
Loading cancer entity…
Cancer
CI-CAN-00000109LIN · LNExplore in graph →
Clinical trials
43 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07408856 | CAN1012 in Pre-Malignant DCIS and LCIS | recruiting | Phase 1 | 24 | Providence Health & ServicesOTHER | 1 | Sep 24, 2026 | clinicaltrials |
| NCT03317405 | Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery | active not recruiting | Phase 1 | 32 | National Cancer Institute (NCI)NIH | 1 | Sep 2, 2026 | clinicaltrials |
| NCT03323658 |
| Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer |
| completed |
| Phase 1 |
| 24 |
| National Cancer Institute (NCI)NIH |
| 1 |
| Jan 10, 2023 |
| clinicaltrials |
| NCT00637481 | A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer | completed | Phase 1 | 66 | National Cancer Institute (NCI)NIH | 1 | Dec 29, 2016 | clinicaltrials |
| NCT01372644 | Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial | completed | Phase 1 | 15 | NYU Langone HealthOTHER | 1 | Dec 5, 2016 | clinicaltrials |
| NCT01077453 | Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer | completed | Phase 1 | 112 | National Cancer Institute (NCI)NIH | 1 | Oct 20, 2014 | clinicaltrials |
Data updated 5 days agoSource updated Sep 24, 2026source: clinicaltrials